GALT
Galectin Therapeutics Inc

10,209
Mkt Cap
$370.11M
Volume
275,328.00
52W High
$6.55
52W Low
$0.726
PE Ratio
-9.71
GALT Fundamentals
Price
$5.74
Prev Close
$5.74
Open
$5.75
50D MA
$5.07
Beta
0.65
Avg. Volume
316,689.22
EPS (Annual)
-$0.7575
P/B
-2.94
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Galectin Therapeutics (NASDAQ:GALT) Insider Sells 121,117 Shares
Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 121,117 shares of the firm's stock in a transaction dated Thursday, November 13th. The shares were sold at an...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Galectin Therapeutics (NASDAQ:GALT) Releases Earnings Results, Misses Estimates By $0.02 EPS
Galectin Therapeutics (NASDAQ:GALT - Get Free Report) announced its earnings results on Friday. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of...
MarketBeat·4d ago
News Placeholder
Khurram Jamil Sells 121,117 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock
Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 121,117 shares of the business's stock in a transaction on Thursday, November 13th. The shares were sold at an...
MarketBeat·5d ago
News Placeholder
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened
Galectin Therapeutics (NASDAQ:GALT) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...
MarketBeat·6d ago
News Placeholder
Galectin Therapeutics (NASDAQ:GALT) CFO Sells $22,898.10 in Stock
Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CFO Jack Callicutt sold 3,810 shares of the business's stock in a transaction dated Monday, November 3rd. The stock was sold at an average...
MarketBeat·14d ago
News Placeholder
Galectin Therapeutics (NASDAQ:GALT) CEO Joel Lewis Sells 14,420 Shares
Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 14,420 shares of Galectin Therapeutics stock in a transaction dated Tuesday, November 4th. The shares were sold at an...
MarketBeat·14d ago
News Placeholder
Galectin Therapeutics (NASDAQ:GALT) CFO Sells $173,778.03 in Stock
Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CFO Jack Callicutt sold 28,629 shares of the company's stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at...
MarketBeat·14d ago
News Placeholder
Galectin Therapeutics Inc. (GALT) Is Up 7.48% in One Week: What You Should Know
Does Galectin Therapeutics Inc. (GALT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·2mo ago
News Placeholder
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024
From Tonix Pharmaceuticals’ progress on fibromyalgia treatments to Nvidia-backed Recursion Pharmaceuticals, these stocks sparked significant message volume growth on Stocktwits.
Stocktwits·11mo ago
News Placeholder
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
read more...
Benzinga·1y ago

Latest GALT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.